A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients

Clinical trial NCT06412471 · UNKNOWN

Trial details

NCT number: NCT06412471
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

First-line Advanced NSCLC Patients

Start date: 2024-07-26
Primary completion: 2025-07-01
Enrollment: 235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.